Brief: IRLAB Therapeutics Q3 Operating Loss Widens To SEK 21.5 Million

IRLAB Therapeutics AB

07/11/2019 07:17

Nov 7 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q3 OPERATING LOSS SEK 21.5 MILLION VERSUS LOSS SEK 15.9
MILLION
YEAR AGO

Source text for Eikon:  ID:nNDLb5rWh2 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))